BRiTE - Bispecific T Cell Engager for Patients With Glioblastoma

Clinical trial NCT04903795 · RECRUITING

Trial details

NCT number: NCT04903795
Sponsor: Mustafa Khasraw, MBChB, MD, FRCP, FRACP
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Newly Diagnosed Glioblastoma Recurrent Glioblastoma

Start date: 2026-08-17
Primary completion: 2027-12-30
Enrollment: 18

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.